Literature DB >> 182198

The B-vitamins in malnutrition with alcoholism. A model of intervitamin relationships.

D K Dastur, N Santhadevi, E V Quadros, F C Avari, N H Wadia, M N Desai, E P Bharucha.   

Abstract

1. The B-vitamin status of fifty-nine patients, mainly from the lower socio-economic classes in Bombay, with a history of chronic malnutrition, and of alcoholism of 1-5-20 years' duration, was studied before and during treatment, and in relation to their clinical, especially neurological, condition. These patients were divided into two neurological categories: (I) those with peripheral neuropathy (mainly sensory and distal) alone, (2) those with mental changes (mainly confusion and disorientation) also. Both categories frequently showed pellagrous pigmentation and mucocutaneous signs of B-vitamin deficiency. 2. Thiamin and erythrocyte transketolase (EC 2.2.1.1) activity, riboflavin, nicotinic acid, pantothenic acid, total and pyridoxal fraction of vitamin B6, folate and total vitamin B12 were estimated in the blood and the cerebrospinal fluid (CSF) of these patients, and also in the blood of sixty-nine control subjects and in the CSF of some of them. The concentrations of all the vitamins, except vitamin B12, were highly significantly lower in the blood of patients of category I compared to the controls, and erythrocyte transketolase activity and pyridoxal concentration in patients of category 2 were significantly lower than those of category I patients. Blood pantothenic acid and folate concentrations were reduced less consistently. 3. Serum vitamin B12 concentration was significantly increased (though within normal range) in the patients compared to the control group, probably because of the moderate hepatic insufficiency (as assessed by liver function tests) in the former. 4. The concentrations of thiamin, riboflavin, nicotinic acid and total vitamin B6 were also highly significantly lower in the CSF in patients of category I compared with controls. Furthermore, thiamin, nicotinic acid and total vitamin B6 concentrations were significantly lower in patients of category 2 than those of category I patients, indicating that CSF levels reflect better the neurological status of these patients. 5. There was a moderate increase in the blood concentration of all the vitamins tested, after a relatively poor hospital diet alone. There was a concurrent increase in the blood levels of thiamin, riboflavin, nicotinic acid and pantothenic acid after parenteral treatment with either thiamin or nicotinic acid. The administration of pyridoxine resulted in a significant increase in the blood levels of riboflavin and the pyridoxal fraction of vitamin B6.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182198     DOI: 10.1079/bjn19760068

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

1.  Mechanisms underlying the differential effects of ethanol on the bioavailability of riboflavin and flavin adenine dinucleotide.

Authors:  J Pinto; Y P Huang; R S Rivlin
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

2.  Subacute sensory ataxia and optic neuropathy with thiamine deficiency.

Authors:  Marco Spinazzi; Corrado Angelini; Cesare Patrini
Journal:  Nat Rev Neurol       Date:  2010-03-23       Impact factor: 42.937

3.  The influence of vitamin B6 deficiency on somatosensory stimulus conduction in the rat.

Authors:  D Claus; B Neundörfer; K Warecka
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

4.  Monophosphate, the only phosphoric ester of thiamin in the cerebro-spinal fluid.

Authors:  G Rindi; C Patrini; M Poloni
Journal:  Experientia       Date:  1981

5.  Thiamine deficiency and nervous system function disturbances.

Authors:  D Claus; R Eggers; K Warecka; B Neundörfer
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 6.  Pellagrous encephalopathy presenting as alcohol withdrawal delirium: a case series and literature review.

Authors:  Mark A Oldham; Ana Ivkovic
Journal:  Addict Sci Clin Pract       Date:  2012-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.